ChinaSavvy lands $1.3 million engineering contract to supply components for high-tech storage systems
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies.
ChinaSavvy is in receipt of a USD 1.3 million order to supply components for high-tech robotic storage systems by Hamilton Storage, a global company with headquarters in Massachusetts, US.
ChinaSavvy is a British owned and managed engineering and manufacturing company based in China. The company, founded in 2003, was established with the primary aim of delivering world-class engineering and manufacturing services to blue-chip companies in the US, UK, Australia and many other countries around the globe, while taking advantage of low Chinese manufacturing costs.
In the bid to achieve world-class engineering in China, Chinasavvy, an ISO 9001-2008 company, recruited highly qualified engineers and tech veterans and coupled them with state-of-the-art technology in the engineering and manufacturing industry. The company has earned a global reputation in the delivery of high quality, world-class engineering and manufacturing services at affordable prices. ChinaSavvy’s customer base is extremely loyal with companies continuing to rely on Chinasavvy for engineering and manufacturing after 10 to 12 years. And Hamilton has already indicated a long-term commitment to Chinasavvy for further components and systems.
The initial US$1.3 million order is to supply components for ultra low temperature robotic storage systems in the US to major pharmaceutical companies. Hamilton Storage, part of the Hamilton group, has operations world-wide and are leaders in this field.
Christopher Devereux, the Managing Director of ChinaSavvy said: “We are committed to ensuring that we deliver exceptional world-class engineering and manufacturing services to Hamilton Storage, to cement the business partnership and prove to them that they have taken the right business decision. Once again we have shown that ‘China pricing’ can go hand in hand with exceptional quality and on-time deliveries. For this order we are combining various manufacturing skills including: aluminium extrusion and punching; laser cutting, die-casting; injection moulding; fabrication and assembly.”
Dave Recchia, Head of Purchasing at Hamilton Storage said:, “Hamilton Storage conducted an extensive search for a new manufacturing partner last summer. During this search our purchasing team discovered ChinaSavvy. It became evident very quickly during the quoting process that ChinaSavvy was unique among other vendors in Asia. We were very impressed with the turnaround time on quotes, the ease of communication in English, and also the highly competitive pricing.”
John Genereux, Director of R&D at Hamilton Storage, added: “As initial work progresses we see ChinaSavvy’s commitment to our project and their deep focus on sound engineering and overall product quality. Hamilton Storage looks forward to a long productive partnership with ChinaSavvy and would recommend them to other companies looking for a highly competent partner in Asia.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.